Human campylobacteriosis in developing countries

Emerging Infectious Diseases

Volumn 8, Issue 3, 2002, Pages 237-243

  Coker, Akitoye O ^a   Isokpehi, Raphael D ^a   Thomas, Bolaji N ^a   Amisu, Kehinde O ^a   Larry Obi, C ^a,b  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b UNIVERSITY OF VENDA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; ERYTHROMYCIN; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATION; CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; CAUSE OF DEATH; CLINICAL FEATURE; DEVELOPING COUNTRY; DISEASE ASSOCIATION; ENTERITIS; EPIDEMIOLOGICAL DATA; GRAM NEGATIVE INFECTION; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PUBLIC HEALTH; REVIEW; SEASONAL VARIATION; TRAVELLER DIARRHEA;

EID: 0036197069     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0803.010233     Document Type: Review

References (76)

1. Campylobacter jejunië - An emerging foodborne pathogen
2. Tropical disease research: Progress 1999-2000
3. Integrated management of childhood illness: A summary of first experiences
4. Campylobacter infections in developing countries
5. Campylobacter infections in developing countries
6. International collaboration on campylobacters: Experience from Lagos, Nigeria
7. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations
8. Gastroenteritis in sentinel general practices, the Netherlands
9. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: Resistance and trends in human isolates
10. Current epidemiological issues in human campylobacteriosis
11. Pathogenicity and convalescent excretion of Campylobacter in rural Egyptian children
12. Post genome analysis of Campylobacter jejuni
13. Incidence of Campylobacter infection in infants in western Algeria and the possible protective role of breast feeding
14. Prevalence of Campylobacter enteritis in children from Yaounde (Cameroon)
15. Campylobacter enteritis among children in north-west Ethiopia: A 1-year prospective study
16. The changing patterns of Campylobacter jejuni/coli in Lagos, Nigeria after ten years
17. Campylobacter jejuni/coli and enterotoxigenic Escherichia coli (ETEC) in faeces from children and adults in Tanzania
18. Campylobacter enteritis in children in an urban community
19. Aetiology of acute diarrhoea in hospitalized children in Rio de Janeiro City, Brazil
20. Infection, diarrhea and dysentery caused by Shigella species and Campylobacter jejuni among Guatemalan rural children
21. A study of the bacterial and parasitic causes of acute diarrhoea in northern Jordan
22. Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh
23. Case-control study of endemic diarrheal disease in Thai children
24. Etiological study of diarrheal patients in Vientiane, Lao People's Democratic Republic
25. Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean island Curacao
26. Age distribution of diarrhoeal and healthy children infected with Campylobacter jejuni
27. Campylobacter immunity and quantitative excretion rates in Thai children
28. Campylobacter jejuni as a cause of acute diarrhoea in children: A study at an urban hospital in Bangladesh
29. Acute Campylobacter jejuni enteritis in 385 hospitalised patients
30. Serotypes & biotypes of Campylobacter jejuni & C. coli from diverse sources in Calcutta
31. A community study on the aetiology of childhood diarrhoea with special reference to Campylobacter jejuni in a semiurban slum of Varanasi, India
32. Biotype and serogroup distribution of Campylobacter isolates from children in Nigeria
33. Biotype and Lior serogroup distribution of enteric Campylobacter isolated from children in Bangui (Central African Republic), and comparison with Penner serotypes
34. Distribution of sero-biotypes of Campylobacter jejuni and C. coli isolated from paediatric patients
35. Correlation between human and animal bio-serogroups of Campylobacter isolates in Nigeria
36. Deoxyribonucleic acid restriction digest patterns in Campylobacter species: A comparison with Penner serotype
37. Prevalence and clinical features of nonjejuni/coli Campylobacter species and related organisms in stool specimens
38. The Cape Town Protocol how to isolate the most campylobacters for your dollar, pound, franc, yen, etc.
39. First isolation of aerotolerant Campylobacter (Arcobacter) strains in Nigeria
40. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Freiburg from 1992 to 2000
41. Epidemiology of campylobacteriosis and development of resistance in Styria, Austria
42. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years
43. Drug resistance in Campylobacter species in England and Wales, 1993-2001
44. Fluoroquinolone resistant Campylobacter jejuni in Philadelphia, 1982-2000
45. Mannsåiker Antibiotic sensitivity pattern of Campylobacter spp recovered over a ten year period from patients residing in Oslo Area
46. Campylobacter jejuni as a cause of traveler's diarrhea: Clinical features and antimicrobial susceptibility
47. Persistent high risk of diarrhea among foreigners in Nepal during the first 2 years of residence
48. Quinolone-resistant Campylobacterjejuni infections in Minnesota, 1992-1998
49. Seasonal variation in etiology of travelers' diarrhea
50. Gastroenteritis due to Campylobacter jejuni in Lagos, Nigeria
51. Campylobacter species and Guillain-Barré syndrome
52. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies
53. Detection of Campylobacter jejuni/C Campylobacterjejuni/C. coli infection in patients with Guillain-Barré syndrome by serology and culture
54. Guillain-Barrésyndrome in South Africa associated with Campylobacterjejuni O:41 strains
55. Genetic characterization of Campylobacter jejuni O:41 isolates in relation with Guillain-Barre syndrome
56. Diversity of Campylobacter species and its impact on patients infected with human immunodeficiency virus
57. Campylobacter infection in HIV+ South African children and adults
58. Etiologies of acute, persistent, and dysenteric diarrheas in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus
59. Trends in under-5 mortality rates and the HIV/AIDS epidemic
60. Campylobacter jejuni-specific serum antibodies are elevated in healthy Bangladeshi children
61. Immune response to Campylobacter jejuni in a rural community in Thailand
62. Immune response to Campylobacter jejuni and Campylobacter coli in a cohort of children from birth to 2 years of age
63. Epidemiologic and clinical features of Campylobacter jejuni infections
64. Campylobacter jejuni antibody in patients with diarrhoea and asymptomatic individuals in Lagos, Nigeria
65. Influence of strain characteristics and immunity on the epidemiology of Campylobacter infections in Thailand
66. Protection of breast-fed infants against Campylobacter diarrhea by antibodies in human milk
67. Cohort study of intestinal infection with Campylobacter in Mexican children
68. Zoonotic infections in Nigeria: Overview from a medical perspective
69. Bioserogroups of Campylobacter species isolated from sheep in Kaduna State, Nigeria
70. Practical intervention strategies for Campylobacter
71. Foods as a source of enteropathogens causing childhood diarrhea in Thailand
72. Retail poultry and beef as sources of Campylobacter jejuni
73. Frequency of isolation of Campylobacter from roasted chicken samples from Mexico City
74. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020
75. Health burden in the Netherlands due to infection with thermophilic Campylo thertmophilic Compylobacter spp